Sample MSDS of Atorvastatin Diepoxide Impurity
SECTION 1 - CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
PRODUCT NAME Atorvastatin Diepoxide Impurity
COMPANY IDENTIFICATION CLEARSYNTH
For information call +1-415-685-4395
CS-EO-00023
SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS # 887470-43-1
CHEMICAL NAME Atorvastatin Diepoxide Impurity
PURITY (%) 98
EINECS# ---
HAZ SYMBOLS ---
RISK PHRASES ---
SECTION 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful if swallowed.

Potential Health Effects
The toxicological properties of this material have not been investigated. Use appropriate procedures to prevent opportunities for direct contact with the skin or eyes and to prevent inhalation. Compound is Non-hazardous, Non-Toxic/Non-Flammable.
SECTION 4 - FIRST AID MEASURES
EYES Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids.
SKIN Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
INGESTION Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
INHALATION Remove from exposure and move to fresh air immediately.
NOTES TO PHYSICIAN ---
SECTION 5 - FIRE FIGHTING MEASURES
GENERAL INFORMATION As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
EXTINGUISHING MEDIA In case of fire, use water, dry chemical, chemical foam, or alcohol-resistant foam.
SECTION 6 - ACCIDENTAL RELEASE MEASURES
GENERAL INFORMATION Use proper personal protective equipment as indicated in Section 8.
SPILLS/LEAKS Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up, then place into a suitable container for disposal.
SECTION 7 - HANDLING and STORAGE
HANDLING Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
STORAGE
SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
ENGINEERING CONTROLS Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
PERSONAL PROTECTIVE EQUIPMENT
EYES Wear safety glasses and chemical goggles if splashing is possible.
SKIN Wear appropriate protective gloves and clothing to prevent skin exposure.
CLOTHING Wear appropriate protective clothing to minimize contact with skin.
RESPIRATORS Wear a NIOSH/MSHA or European Standard EN 149 approved full-face piece airline respirator in the positive pressure mode with emergency escape provisions.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
PHYSICAL STATE Not available
COLOR Not available
ODOR Not available
pH Not available
VAPOR PRESSURE Not available
VISCOSITY Not available
BOILING POINT Not available
MELTING POINT Not available
AUTO IGNITION TEMPERATURE Not available
FLASH POINT Not available
EXPLOSION LIMITS, LOWER Not available
EXPLOSION LIMITS, UPPER Not available
SOLUBILITY IN WATER Not available
LOSS ON DRYING Not available
SPECIFIC GRAVITY/DENSITY Not available
MOLECULAR FORMULA C33H35FN2O7
MOLECULAR WEIGHT 590.6 g/mol
SECTION 10 - STABILITY AND REACTIVITY
CHEMICAL STABILITY Stable under normal temperatures and pressures.
CONDITIONS TO AVOID Incompatible materials, strong oxidants.
INCOMPATIBILITIES WITH OTHER MATERIALS Strong oxidizing agents, strong bases.
HAZARDOUS DECOMPOSITION PRODUCTS Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, nitrogen.
HAZARDOUS POLYMERIZATION Has not been reported.
SECTION 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS#: LD50/LC50:
CAS#:Draize test, Rabbit, eye: NA
Mouse: NA , Rabbit: NA, rat: NA.
Carcinogenicity:
Salicylamide -
Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
See actual entry in RTECS for complete information.
SECTION 12 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.
SECTION 13 - TRANSPORT INFORMATION
IATA No information available. IMO No information available. RID/ADR No information available.
SECTION 14 - REGULATORY INFORMATION
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 22 Harmful if swallowed.
Safety Phrases:
WGK (Water Danger/Protection)
CAS#United Kingdom Occupational Exposure Limits

United Kingdom Maximum Exposure Limits

Canada
CAS is listed on Canada's DSL List.
CAS is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS is listed on the TSCA inventory.
SECTION 15 - ADDITIONAL INFORMATION
The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

Mallikharjuna Reddy
Sr. Manager - (Quality Control)
sales@clearsynth.com | www.clearsynth.com | Worldwide Helpline No:- +1-415-685-4395 | CIN : U24100MH2010PLC201433
"The 'Catalyst' in making your research work"